GenAI job postings rise across Europe: Which countries lead the way?
'Nearly every job will be impacted by AI (artificial intelligence) at some point,' said Pawel Adrjan, Director of Economic Research at Indeed.
In major European economies, the share of GenAI-related job postings more than doubled in the 12 months to March 2025, according to the global hiring platform Indeed.
GenAI jobs refer to roles involving the development, implementation, or oversight of generative artificial intelligence technologies.
This could include positions building GenAI features, or roles leveraging this tech to create more efficient processes such as reviewing data, summarising reports, or drafting written or creative materials.
Ireland is leading the way by a significant extent in Europe when it comes to these kinds of jobs. Indeed data shows that, as of 31 March 2025, more than 0.7% of Irish job postings include terms related to GenAI.
This is an increase of 204%, with the share more than tripling in just one year. The figure was only 0.02% in the same period in 2023, highlighting a tremendous rise over the past two years.
For comparison, job openings in Ireland for chefs currently represent 1.1% of total postings. Opportunities for lorry drivers and bartenders represent 0.8% and 0.6% respectively.
These figures highlight Ireland's position at the forefront of digital innovation in the European labour market.
"Ireland's leading presence in GenAI job postings reflects the country's well-established technology sector and its role as a European base for many global firms,' Pawel Adrjan told Euronews Business.
'With a high concentration of tech employers, including major multinationals and a number of start-ups, it's natural we would see a proportionate increase in GenAI roles there too,' he added.
Globally recognised names such as Alphabet, Amazon, Apple, Meta, IBM, Intel, Microsoft, Oracle, Salesforce, and Tencent, among many others, have established significant European operations in Ireland.
Adrjan of Indeed also noted that the steady growth in AI-related roles is also indicative of Ireland's focus on industries like software, financial services, and life sciences, which are increasingly integrating AI tools into their operations.
Several major EU and international markets — including Germany, France, Australia, the US, the UK, and Canada — lag behind Ireland in incorporating GenAI into job roles. In each of these countries, the share of job postings mentioning GenAI remains at or below 0.3% as of late March 2025.
However, the share has risen by around 100% or more in these European countries over the past year. This highlights how the job market is evolving, even if still well behind Ireland's 204% increase.
Related
Highest-paying jobs in Germany: Official data and job postings reveal top salaries
Jobs market at a crossroads: Which are the fastest growing and declining jobs?
The UK has the highest share of GenAI-related job postings among the three largest European economies, at 0.33% as of 31 March 2025. That's up 120% from 0.15% the previous year.
Germany follows with 0.23% (a 109% annual increase), and France at 0.21% (a 91% increase).
GenAI jobs appear across a range of categories. Among the top occupations in Ireland where job postings mention GenAI, mathematics leads by a wide margin. As of March 2025, 14.7% of advertised roles in mathematics referenced GenAI, significantly higher than any other category. This was followed by software development (4.9%), media & communications (3.9%), architecture (2.4%), and scientific research & development (2.1%).
Other fields showing notable GenAI activity include industrial engineering (1.8%), legal (1.7%), marketing (1.6%), medical information (1.5%), and production & manufacturing (0.9%).
Pawel Adrjan explained that in many developed markets, ageing populations are contributing to labour shortages and widening skills gaps. As a result, employers face growing competition for talent and are increasingly turning to skills-first hiring approaches, including the use of AI to expand and enhance their workforce.
While nearly every job will be impacted by AI at some point, Adrjan emphasised that human intelligence remains a key requirement.
'We know that GenAI tools are an excellent resource to enhance efficiencies, but they are currently limited in comparison to human expertise,' he said.
Joint research by Indeed and the World Economic Forum earlier this year showed that humans will remain an essential part of the global workforce as AI continues to evolve.
Indeed analysed over 2,800 work-related skills to assess GenAI's potential to substitute employees. The findings show that around two-thirds (69%) are unlikely to be replaced by GenAI, underscoring the continued importance of human expertise in the workplace.
The chart above shows the likelihood of certain skills to be replaced or substituted by GenAI. They are ranked from 'very low capacity' (hard to replace) to 'high capacity' (easy to replace).
AI and Big Data, as well as reading, writing, and mathematics are on the 'high capacity' side of the scale. On the 'very low capacity' side of the scale, we can see sensory-processing abilities, along with empathy and active listening.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Intel (NasdaqGS:INTC) Unveils AI-Enhanced ePaper Touchpad for Innovative Laptop Experience
Intel saw a 17% upward price movement over the last month, a striking performance that stands out amidst tech sector advancements. This gain aligns with significant developments, like the launch of a groundbreaking ePaper touchpad solution by E Ink Holdings in collaboration with Intel technologies. Additionally, strategic partnerships and leadership changes at Intel, coupled with broader tech sector optimism seen in Nasdaq gains, likely added to the positive sentiment. Market dynamics suggest that Intel's recent moves align well with investor focus on tech innovation and strategic repositioning, which could lend further confidence to the company's future endeavors. Buy, Hold or Sell Intel? View our complete analysis and fair value estimate and you decide. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The recent collaboration between E Ink Holdings and Intel, combined with strategic partnerships and changes in leadership, holds the potential to impact Intel's ongoing transformation efforts positively. As Intel grapples with organizational complexity and seeks to enhance its innovation play in AI and foundry businesses, these developments could prove crucial in offsetting complexity risks and boosting investor confidence. Despite a 17% rise in its share price over the past month, Intel's longer-term performance remains concerning, with a total return, including dividends, of 25.99% decline over the last year. This performance, when compared to the broader industry, highlights the ongoing challenges Intel faces in achieving growth amid tech sector advancements. Revenue and earnings forecasts could reflect optimism from recent strategic moves. However, broader market dynamics underline critical risks, such as reliance on older manufacturing nodes and geopolitical uncertainties. Analysts currently predict revenue growth of 2.5% annually, which is slower than the overall US market's 8.7% per year growth. Intel's focus on AI and structural transformation could influence future earnings, presenting a pathway for improvement, though benefits may take time to materialize. As the current share price of US$19.94 remains below the average analyst price target of US$21.29, this suggests Intel might still be perceived as undervalued relative to its fair value potential, presenting a mixed outlook for investors as they assess the company's transitional journey. Evaluate Intel's historical performance by accessing our past performance report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:INTC. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati


Fast Company
20 minutes ago
- Fast Company
New AI outlines lung tumors better and faster than doctors, study finds
Scientists have developed a revolutionary new AI tool which, according to a new study, may become crucial in lung cancer screening and treatment. The study, published in the journal npj Precision Oncology, explored the capabilities of a new device, developed by a team at Northwestern Medicine. The device is called iSeg, which comes from its ability to perform tumor segmentation (online or mapping tumors). The traditional process of tumor segmentation is complex and poses challenges for doctors. It can also take multiple doctors visits, several scans, and a great deal of time. In one study, manual segmentation required 12 scans and took doctors seven hours to complete the manual tumor mapping. Other AI tools have been developed for cancer screenings, however, those tools used static images. iSeg uses 3D imagery for a deeper understanding of the tumor, including how it moves as a patient breathes—an important factor in determining treatment plans. iSeg's clearer mapping also means it exposes areas that doctors may miss while using manual segmentation. In the study, after the AI was trained, iSeg was shown scans it had never seen, and was tasked with outlining tumors. When compared to outlines drawn by physicians, iSeg matched experts' drawings, but it also flagged additional areas that doctors couldn't see. Interestingly, those areas turned out to be critical, as they are often linked to more serious diagnoses and worse outcomes if overlooked. 'We're one step closer to cancer treatments that are even more precise than any of us imagined just a decade ago,' said Dr. Mohamed Abazeed, senior author of the study, and chair and professor of radiation oncology at Northwestern University Feinberg School of Medicine. 'The goal of this technology is to give our doctors better tools,' added Abazeed. Other experts say AI technology is important when it comes to lung cancer patients, not only because it can save lives, but also because it may help close care gaps that lead to underdiagnosing for certain groups due to socioeconomic factors. Pulmonologist Stephen Kuperberg, MPH '24, and David Christiani, Elkan Blout Professor of Environmental Genetics at Harvard T.H. Chan School of Public Health, explained in a June commentary that cancer screening rates are lower among high-risk patients from Black and Latinx neighborhoods. 'The underlying reasons for poor uptake within this population are complex, including structural racism and social and cultural factors,' they wrote, urging the 'vital need' for more AI tools which can help with 'optimal data collection.' Currently, the glaring gap in early detection leads to higher mortality from the disease for those groups. They added, 'AI technologies will transform reporting, collecting, and processing population data, whether in public datasets and repositories or within institutions, paving the way for discovery and methodology development in lung cancer detection.'
Yahoo
22 minutes ago
- Yahoo
SharkNinja Maintains 9.5% Sales Target Despite Tariffs and Inventory Disruptions
SharkNinja, Inc. (NYSE:SN) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. On June 3, William Blair reiterated its Outperform rating for SharkNinja, Inc. (NYSE:SN). The update was made amid persistent issues with inventory shortages and tariffs, which are anticipated to affect the company's performance in the second quarter. According to the firm, customer demand is still steady, but the supply of key products—especially those sold under the Ninja brand—is being impacted by the brief suspension of orders from China. That said, SharkNinja Inc. (NYSE:SN) believes it can still reach its sales growth target of 9.5% for the quarter despite these obstacles. In addition to contemplating domestic manufacture for some products, SharkNinja Inc. (NYSE:SN) is actively expanding its supply chain. To maintain inventories, the company has also hiked prices on roughly 32% of its product line since mid-April, which might have an impact on short-term demand. Despite these obstacles, SharkNinja Inc. (NYSE:SN) hopes to potentially accelerate its gains in market share later in the year as inventory levels level out. SharkNinja Inc. (NYSE:SN) is a technology and product design company that operates under the Shark and Ninja brands. It provides consumer solutions for home appliances, cleaning, cooking, food preparation, and cosmetics. While we acknowledge the potential of SN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data